bullish

Anthem Biosciences IPO Trading - Robust Insti Coverage Drives Overall Demand

628 Views18 Jul 2025 11:07
Anthem Biosciences (ABS) raised about US$397m in its India IPO. In this note, we will talk about the demand and trading dynamics.
What is covered in the Full Insight:
  • Introduction to Anthem Biosciences
  • Investor Allocation and Anchor Book Coverage
  • Past IPO Performance in India
  • Valuation Comparison with Peers
  • Future Growth Prospects and Upside
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
x